ID

14105

Descripción

Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01507311

Link

https://clinicaltrials.gov/show/NCT01507311

Palabras clave

Versiones (1)
  1. 29/3/16 29/3/16 -
Subido en

29 de marzo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes NCT01507311

Inglés

Eligibility Diabetes NCT01507311

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01507311
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosed with type 2 diabetes, either newly diagnosed with at least two months of diet treatment, or in current oha (oral hypoglycaemic agent) treatment with stable dose for at least six months
Descripción

Type 2 diabetes and treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0011878
UMLS CUI [3]
C0359086
bmi (body mass index) between 24 and 35 kg/m^2 (both inclusive)
Descripción

BMI

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
fasting plasma glucose between 6 and 15 mmol/l (both inclusive)
Descripción

Fasting plasma glucose

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0583513
anti-gad (glutamic acid decarboxylase) negative
Descripción

Anti-gad

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1167898
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
known or suspected allergy to trial product or related products
Descripción

Allergy to trial product

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3854006
receipt of any investigational drug within three months prior to this trial
Descripción

Experimental drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0304229
recurrent severe hypoglycaemia as judged by the investigator
Descripción

Recurrent severe hypoglycaemia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0342316
cardiac disease or any clinically significant abnormal ecg (electrocardiogram)
Descripción

Cardiac disease or ECG

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0013798
use of any drug (except oral hypoglycaemic agents (ohas)) which in the investigator's opinion could interfere
Descripción

Pharmacotherapy and drug interactions

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C0687133
with the blood glucose level (i.e., insulin, systemic corticosteroids, thiazides)
Descripción

Medication interferring with blood glucose level

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392201
UMLS CUI [1,2]
C0013216
UMLS CUI [1,3]
C0687133
liver or renal disease
Descripción

Liver or renal disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0022658
Volver a la parte superior de la página

Similar models

Eligibility Diabetes NCT01507311

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01507311
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Type 2 diabetes and treatment
Item
diagnosed with type 2 diabetes, either newly diagnosed with at least two months of diet treatment, or in current oha (oral hypoglycaemic agent) treatment with stable dose for at least six months
boolean
C0011860 (UMLS CUI [1])
C0011878 (UMLS CUI [2])
C0359086 (UMLS CUI [3])
BMI
Item
bmi (body mass index) between 24 and 35 kg/m^2 (both inclusive)
boolean
C1305855 (UMLS CUI [1])
Fasting plasma glucose
Item
fasting plasma glucose between 6 and 15 mmol/l (both inclusive)
boolean
C0583513 (UMLS CUI [1])
Anti-gad
Item
anti-gad (glutamic acid decarboxylase) negative
boolean
C1167898 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Allergy to trial product
Item
known or suspected allergy to trial product or related products
boolean
C0020517 (UMLS CUI [1,1])
C3854006 (UMLS CUI [1,2])
Experimental drugs
Item
receipt of any investigational drug within three months prior to this trial
boolean
C0304229 (UMLS CUI [1])
Recurrent severe hypoglycaemia
Item
recurrent severe hypoglycaemia as judged by the investigator
boolean
C0342316 (UMLS CUI [1])
Cardiac disease or ECG
Item
cardiac disease or any clinically significant abnormal ecg (electrocardiogram)
boolean
C0018799 (UMLS CUI [1])
C0013798 (UMLS CUI [2])
Pharmacotherapy and drug interactions
Item
use of any drug (except oral hypoglycaemic agents (ohas)) which in the investigator's opinion could interfere
boolean
C0013216 (UMLS CUI [1,1])
C0687133 (UMLS CUI [1,2])
Medication interferring with blood glucose level
Item
with the blood glucose level (i.e., insulin, systemic corticosteroids, thiazides)
boolean
C0392201 (UMLS CUI [1,1])
C0013216 (UMLS CUI [1,2])
C0687133 (UMLS CUI [1,3])
Liver or renal disease
Item
liver or renal disease
boolean
C0023895 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial